Cambodia vs Yemen: Treatment coverage for schistosomiasis
Cambodia
76.0%
in 2024
Yemen
78.7%
in 2022
Cambodia rank
10th
Yemen rank
9th
Treatment coverage for schistosomiasis over time
- Cambodia
- Yemen
How they compare
Yemen currently reports 78.7% against 76.0% in Cambodia, a difference of 2.7%.
The two have swapped places 5 times across 14 shared years of data; in 2008 it was Cambodia ahead.
Cambodia ranks 10th and Yemen ranks 9th of 45 countries.
Cambodia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 88.3% | 7.5% | 80.9% | Cambodia |
| 2010s | 86.6% | 59.6% | 27.0% | Cambodia |
| 2020s | 69.3% | 67.6% | 1.7% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Cambodia or Yemen?
- Yemen, at 78.7% against 76.0% in Cambodia as of 2022.
- What is the difference in treatment coverage for schistosomiasis between Cambodia and Yemen?
- 2.7%, with Yemen ahead.
- How many years of comparable data are there for Cambodia and Yemen?
- 14 years are reported by both, from 2008 to 2022.
- How do Cambodia and Yemen rank globally for treatment coverage for schistosomiasis?
- Cambodia ranks 10th and Yemen ranks 9th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.